Iron deficiency and short-term adverse events in patients with decompensated heart failure

Background For patients with heart failure (HF), iron deficiency (ID) is a common therapeutic target. However, little is known about the utility of transferrin saturation (TSAT) or serum ferritin for risk stratification in decompensated HF (DHF) or the European Society of Cardiology's (ESC) cur...

Ausführliche Beschreibung